New Hebrew daily set for January

The project will cost between $35 and $40 million to run in the first three years of operation.

December 25, 2005 08:31
1 minute read.


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


The Hirsch Media Group, made up of investors from the US and Europe and controlled by Shlomo Ben Zvi, said this week it is set to launch a new daily Hebrew newspaper Israeli News on January 3. The project will cost between $35 and $40 million to run in the first three years of operation. The paper, which will be based on the format of the US publication Metro, will be distributed free of charge to lunch time passengers on the country's train lines. Sources close to the company said it plans on printing enough copies to make it the second most widely read paper in Israel. Shlomo Ben Zvi owns various media outlets in Israel, including religious cable TV channel Tchelet and weekly newspaper Mekor Rishon.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection